The deficiency of RASSF1A, which results in the activation of YAP, is a crucial factor in the acquisition of a malignant phenotype, invasive and antiapoptotic properties, and eventual transformation into cancer cells by bronchial epithelial cells [9]. The gene discussed is RASSF1; the disease is cancer.